Morepen Laboratories Ltd. (MOREPENLAB) 52 Week High Streak: Second Straight Session Explained

Morepen Laboratories Ltd. 52 Week High Streak has now extended for its second straight session, with the stock rising 8.54% across the streak and touching a fresh 52-week high of Rs 129.55. At the latest reading, Morepen Laboratories Ltd. 52 Week High Streak was reflected in a price of Rs 128.95. The latest figures confirm the repeated-high pattern, but they do not establish a company-specific catalyst for the move.

Morepen Laboratories Ltd. 52 Week High Streak sits alongside a previous close of Rs 126, an opening price of Rs 125.95 and a low of Rs 125.2 during the period. Turnover stood at Rs 16.02 crore, while market capitalisation was Rs 6,509.69 crore. For readers, the repeated-high pattern carries a different meaning from a single breakout: it shows that the stock has kept revisiting a fresh one-year high across sessions, rather than doing so only once.

Morepen Laboratories 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 128.95
Previous Close	Rs 126
Today's Move	+Rs 2.95 (+2.34%)
Open	Rs 125.95
High	Rs 129.55
Low	Rs 125.2
Market Capitalisation	Rs 6,509.69 crore

Morepen Laboratories Ltd. (MOREPENLAB) traded at Rs 128.95 versus the previous close of Rs 126, a rise of 2.34%. The stock opened at Rs 125.95, reached a high of Rs 129.55 and touched a low of Rs 125.2.

Morepen Laboratories Ltd. 52 Week High Streak is visible in today’s price action as well, with the stock trading at Rs 128.95 after a gain of Rs 2.95, or 2.34%, versus the previous close. The session opened at Rs 125.95, moved to a high of Rs 129.55 and a low of Rs 125.2, and the latest price stood near the upper end of that range. Morepen Laboratories Ltd. 52 Week High Streak therefore combines a fresh yearly high with a day that kept the stock above the prior close for most of the observed range.

Turnover of Rs 16.02 crore gives a factual measure of traded value during the move, while market capitalisation of Rs 6,509.69 crore places the company in a sizeable listed pharmaceutical name within its peer set. Morepen Laboratories Ltd. 52 Week High Streak matters here because the fresh peak was not a one-off print; it followed the earlier session’s breakout and has now been repeated. That distinction is useful for readers tracking whether the stock is simply testing a level or continuing to reset the one-year range.

What the Repeated 52-Week Highs Show

Morepen Laboratories Ltd. 52 Week High Streak suggests that the stock has kept making new one-year highs across consecutive sessions, with the latest peak extending the move from the first breakout. The cumulative advance across the streak is 8.54%, which is the key number to watch because it captures the full run rather than just the latest day. Morepen Laboratories Ltd. 52 Week High Streak also shows that the present high of Rs 129.55 is the relevant reference point for the current range.

What the repeated highs show is a continued reset in the stock’s one-year price reference, not a single-day event that was left behind. Morepen Laboratories Ltd. 52 Week High Streak is therefore better read as a sequence of fresh peaks than as a standalone intraday move. The latest market data confirms the pattern, while the reason behind it remains unstated in the price record itself. For investors, that means the focus stays on whether the stock can keep trading near the new high zone and whether the latest re-rating in price can be matched by business performance over time.

Morepen Laboratories Ltd. (MOREPENLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 6,509.69 crore
P/E Ratio	49.13x
P/B Ratio	5.3x
ROE	7.96%
ROCE	10.19%
EPS	Rs 2.56
Book Value Per Share	Rs 23.78
Dividend Yield	0.16%

Morepen Laboratories Ltd. (MOREPENLAB) fundamental metrics show P/E 49.13x, P/B 5.3x, ROE 7.96%, ROCE 10.19%. Taken on their own, these numbers offer context rather than a trading signal.

Morepen Laboratories Ltd. has a market capitalisation of Rs 6,509.69 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 49.13x, P/B at 5.3x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 7.96% and ROCE of 10.19%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 2.56, book value per share of Rs 23.78, dividend yield of 0.16%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.01x, median ROE of 11.74%, median ROCE of 13.63%. They set out the fundamental picture and are not a rating on the stock.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	49.13x
Benchmark Median P/E	32.01x
Benchmark Average P/E	49.17x
Benchmark P/E Range	3.4x to 688.17x
Company P/B Ratio	5.3x
Benchmark Median P/B	2.92x
Company ROE	7.96%
Benchmark Median ROE	11.74%
Company ROCE	10.19%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 6,509.69 crore
Benchmark Median Market Cap	Rs 765.11 crore

Morepen Laboratories Ltd. (MOREPENLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 49.13x, which is above the benchmark median of 32.01x, a difference of +53.48%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Morepen Laboratories Ltd. (MOREPENLAB) has a ROE of 7.96%, which is below the benchmark median of 11.74%, a difference of -32.2%. Morepen Laboratories Ltd. (MOREPENLAB) has a ROCE of 10.19%, which is below the benchmark median of 13.63%, a difference of -25.24%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
SENORES PHARMACEUTICALS L	SENORES	6,459.48	50.45	6.61	14.14	15.66
Orchid Pharma Ltd.	ORCHPHARMA	6,057.69	688.17	3.81	0.7	1.11
Sanofi India Ltd.	SANOFI	7,072.59	21.76	8.53	44.5	55.46
IOL Chemicals And Pharmaceuticals Ltd.	IOLCP	5,911.64	36.18	3.26	7.9	10.65
Innova Captab Ltd.	INNOVACAP	7,282.44	42.4	5.84	13.75	15.04

Morepen Laboratories Ltd. (MOREPENLAB) has a P/E ratio of 49.13x compared with the displayed peer median of 42.4x. The comparison is relative and should not be read as a recommendation. Its ROE of 7.96% compares with a peer median of 13.75% across the companies shown in the table. ROCE stood at 10.19% versus the displayed peer median of 15.04%, providing a capital-efficiency comparison. Morepen Laboratories Ltd. (MOREPENLAB) has a market capitalisation of Rs 6,509.69 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Morepen Laboratories

• Morepen Laboratories Ltd. 52 Week High Streak has reached a second straight session, which keeps the stock at a fresh one-year peak.
• The cumulative move across Morepen Laboratories Ltd. 52 Week High Streak is 8.54%, the key figure that captures the full run.
• The latest high of Rs 129.55 is above the previous close of Rs 126, showing the new reference point for the stock price.
• Valuation sits at a P/E of 49.13 and a P/B of 5.3, both above the industry medians in the latest benchmark set.
• ROE of 7.96% and ROCE of 10.19% remain below the sector medians, so business returns need to be read alongside the price move.

About Morepen Laboratories Ltd.

The stock’s ROE, ROCE, EPS, book value and dividend yield give the core operating backdrop for the current run. Morepen Laboratories Ltd. 52 Week High Streak is most useful to readers who want to connect the fresh yearly high with the company’s current valuation and profit-return profile. That is the practical lens here: the stock has reset its one-year high twice in succession, and the business metrics show where that reset sits against the underlying fundamentals.

Track Morepen Laboratories Ltd. on Univest

Morepen Laboratories Ltd. 52 Week High Streak can be followed on the company’s stock page for updated price, valuation and company information. Readers tracking Morepen Laboratories Ltd. 52 Week High Streak should watch the next traded price relative to the new high zone, the streak’s continuation, and whether the valuation remains in line with the company’s reported financial ratios.

Frequently Asked Questions

What is Morepen Laboratories Ltd. 52 Week High Streak?

Ans. Morepen Laboratories Ltd. 52 Week High Streak means the stock has set a fresh 52-week high in consecutive sessions. In this case, the streak has reached a second straight session, with the latest high at Rs 129.55 and the cumulative move at 8.54%.

How many sessions has Morepen Laboratories set a fresh 52-week high?

Ans. Morepen Laboratories Ltd. 52 Week High Streak has extended for two consecutive sessions.

What is the cumulative move in Morepen Laboratories Ltd. 52 Week High Streak?

Ans. The cumulative move across Morepen Laboratories Ltd. 52 Week High Streak is 8.54%. That figure measures the full advance across the streak, rather than only the latest session’s change.

What is the current 52-week high for Morepen Laboratories?

Ans. The latest 52-week high for Morepen Laboratories Ltd. is Rs 129.55. Morepen Laboratories Ltd. 52 Week High Streak uses that level as the current peak in the ongoing repeated-high pattern.

How does the current price compare with the previous close?

Ans. The stock last traded at Rs 128.95 compared with the previous close of Rs 126. That translates into a gain of Rs 2.95, or 2.34%, during the observed period.

Is there a confirmed company-specific catalyst for the streak?

Ans. The price record confirms the repeated-high pattern, but it does not establish a company-specific catalyst for Morepen Laboratories Ltd. 52 Week High Streak. Readers should treat the cause as unconfirmed unless a separate factual item is explicitly provided.

How does Morepen Laboratories compare with its healthcare peers on valuation?

Ans. Morepen Laboratories trades at a P/E of 49.13 and a P/B of 5.3, above the industry medians of 32.01 and 2.92. Morepen Laboratories Ltd. 52 Week High Streak therefore leaves the stock priced above the typical peer midpoint in this sample.

What should investors watch next in Morepen Laboratories Ltd. 52 Week High Streak?

Ans. Investors can watch whether the stock continues to trade near the new high zone, how the valuation compares with future earnings and book-value updates, and whether the repeated-high pattern is sustained in upcoming sessions. Those are the key checks around Morepen Laboratories Ltd. 52 Week.

Track Morepen Laboratories Ltd. (MOREPENLAB) Share Price on Univest

Use Morepen Laboratories Ltd. (MOREPENLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.